Treatment Approach for Patients With Metastatic CRPC
Expert perspectives on the treatment approach for patients with metastatic castrate-resistant prostate cancer.
Source: curetoday.com
Profound Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Profound Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Profound Trial Today - Breaking & Trending Today
NICE Guidance Supports Olaparib Use in BRCA-Mutant Breast, Prostate Cancer
The National Institute for Health and Care Excellence announced final draft guidance recommending the PARP inhibitor olaparib for patients with HER2-negative, high-risk early breast cancer harboring a BRCA1/2 mutation, as well as for those with previously treated hormone-relapsed metastatic prostate cancer with a BRCA1/2 mutation.
Source: onclive.com